“孕产期心身障碍临床路径”研究进展  

Research Development in “Clinical Pathway for Psychosomatic Disorder in Pregnancy and Puerperium”

作　　者：秦峰 李丽娟[2] 张立新 蓝海英 郜正美 赵亚娟[6] 郭存玲 李凤贤 QIN Feng;LI Lijuan;ZHANG Lixin;LAN Haiying;GAO Zhengmei;ZHAO Yajuan;GUO Cunling;LI Fengxian(General Research Group of National Clinic for Maternal Psychosomatic Health,Beijing 100161, China;Maternal and Child Health Care Center of Chinese Center for Disease Control and Prevention,Beijing 100098,China;Research Base in Clinic for Maternal Psychosomatic Health of Dagang Maternal and Child Health Care Center,Tianjin 300270,China;Research Base in Clinic for Maternal Psychosomatic Health of Maternal and Child Health Care Hospital,Yuexiu District,Guangzhou Guangdong 510055,China;Research Base in Clinic for Maternal Psychosomatic Health of Centre for Maternal-Child Health and Family Planning Services,Ling’an District,Hangzhou Zhejiang 311300,China;Research Base in Clinic for Maternal Psychosomatic Health of Taihe Hospital,Shiyan Hubei 442000,China;Research Base in Clinic for Maternal Psychosomatic Health of Jiaozuo Maternal and Child Health Care Hospital,Jiaozuo He’nan 454001,China;Research Base in Clinic for Maternal Psychosomatic Health of Meihekou Maternal and Child Health Care Hospital,Meihekou Jilin 135000,China)

机构地区：[1]全国孕产妇心身健康门诊总课题组,北京100161 [2]中国疾病预防控制中心妇幼保健中心,北京100098 [3]天津市大港妇女儿童保健中心孕产妇心身健康门诊研究基地,天津300270 [4]广州市越秀区妇幼保健院孕产妇心身健康门诊研究基地,广东广州510055 [5]杭州市临安区妇幼保健计划生育服务中心孕产妇心身健康门诊研究基地,浙江杭州311300 [6]十堰市太和医院孕产妇心身健康门诊研究基地,湖北十堰442000 [7]焦作市妇幼保健院孕产妇心身健康门诊研究基地,河南焦作454001 [8]梅河口市妇幼保健院孕产妇心身健康门诊研究基地,吉林梅河口135000

出　　处：《中国卫生标准管理》2018年第23期33-37,共5页China Health Standard Management

摘　　要：孕产期心身障碍(PSD)症状可与孕期因子宫增大以及血液中如绒毛膜促性腺激素及孕激素水平增高等生理变化症状交叉,也可作为产科风险因素症状第二因素参与病情发展。全国孕产妇心身健康门诊总课题组为解决这一医学难题,通过7年时间螺旋性开展"孕产妇心身健康门诊及孕产期心身障碍诊疗体系的创建与应用"创新医疗研究,创建基于围产和产科设立的孕产妇心身健康门诊医疗模式,制定适宜围产和产科医护人员应用的孕产期心身障碍临床诊疗体系和孕产期心身障碍临床路径,实现了在产检中增加孕产期心身障碍筛检和应用多学科合作(PPM)临床诊疗系统及时对罹患孕产期心身障碍的孕妇给予心身同治、共治,取得了显著疗效。随着临床研究的深化发展,总课题组对既往研究标准进行必要的修订,制定基于围产和产科设立的孕产妇心身健康门诊研究基地《孕产期心身障碍临床路径(2018版)》。Psychosomatic disorder(PSD)during pregnancy can be intersected with the physiological changes such as hysterauxesis,elevated human chorionic gonadotropin and growing progestational hormone.It can also be used as a second factor in the symptoms of obstetric risk factors that contributes to the development of the illness.Aiming to solve the above-mentioned medical problem,the National General Research Group of Maternal Psychosomatic Health Clinic helically carried out an innovative medical research of“The Establishment and Application of the Psychosomatic Health Clinic and the Diagnosis and Treatment System of PSD During Pregnancy and Puerperal Period”in the past seven years.Besides,the Research Group promoted the construction of medical model of Maternal Psychosomatic Health Clinic based on Perinatal and Obstetric Departments,as well as the establishment of clinical diagnosis and treatment system of PSD during pregnancy and puerperal period and the clinical pathway of PSD during pregnancy and puerperal period suitable for perinatal and obstetric medical staff.Consequently,it contributes to increasing the screening of PSD during pregnancy and parturition,and applying multidisciplinary cooperation(PPM)clinical diagnosis and treatment system to give psychosomatic intervention to pregnant women with PSD during pregnancy and parturition,resulting in the achievement of significant therapeutic effects.With the deepening development of clinical research,The head research group has revised previous research criteria and formulated the maternity and psychosomatic health clinic research base on the basis of perinatal and obstetrical department Clinical Pathway of Psychosomatic Disorders in Pregnancy(version 2018).

关 键 词：焦虑 抑郁 心理生理性障碍 躯体型障碍 心身障碍 临床路径 孕妇 产妇 

分 类 号：R715[医药卫生—妇产科学]